📌 Key Takeaways
- Topic: Fumed Silica Market 2026: Size, Growth, Key Players and Forecast
- Keywords: precipitated silica
- Published: 2026-11-20 14:20:08
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Talc Powder vs Silica: Differences and Which Filler to Choose
- Transparent Silica Filler: How to Keep Clarity in Coatings and Resins
- Mesoporous silica nanoparticles (MSNs) are a flexible platform for the improvement of water solubility and bioavailability of poorly water-soluble drugs through the stabilization of the API in the amorphous state. Two outstanding mechanisms facilitate such stabilization: physical entrapment within nanoscale pores with a diameter less than the size of the critical nucleus. In this case, the ordered molecular packing necessary to develop crystals cannot advance. Moreover, the unique interactions between the functional groups of APIs and the surface silanol groups of MSNs may immobilize drug molecules at or close to pore walls [ 44, 45 ]. Bavnhøj et al. used celecoxib to demonstrate that when loading is conducted under the pore-filling ability (PFC) of the silica matrix, the drug will be physically stable and amorphous for at least 18 months of dry storage. PFC-loaded along with near-PFC-loaded samples recrystallized, especially upon exposure to moisture, demonstrating the razor-thin margin between the level of loading and stability [ 46 ]. Although advantages are present, long-term stability is undermined by stress recrystallization. For example, α-mangostin began to recrystallize after 7-14 days at 25 °C and 95% relative humidity in MSNs with slightly broader pore size than the molecular size of the API, indicating that pore size must be finely tuned for productive confinement [ 47 ]. Similarly, simvastatin had the longest amorphous lifespan when loaded into pores of 4.5 nm. Still, it exhibited rapid recrystallization in materials with bigger pore size, underlining the critical importance of pore size for the preservation of amorphous stability [ 45, 47 ].
- Silica MSDS: How to Read It and What Safety Information to Check
- Mathematical modeling, particularly the application of the Fick diffusion equation, is really beneficial in clarifying and predicting drug release from polymeric or porous matrices. Fick's laws describe diffusion as the movement of molecules from a greatly concentrated region to a region where the concentration is lower. Fick's first law presumes the diffusion flux to be directly proportional to the concentration gradient. Fick's second law controls the spatial and temporal change in concentration in the release medium [ 59 ]. For drug release, the general equation is as follows (Equation (3)).
- Silica as an Excipient: Functions, Grades and Pharmaceutical Applications
- What Is Quartz? Crystalline Silica Properties, Grades and Industrial Applications
- 69. Qi G., Shi G., Wang S., Hu H., Zhang Z., Yin Q., Li Z., Hao L. A Novel pH-Responsive Iron Oxide Core-Shell Magnetic Mesoporous Silica Nanoparticle (M-MSN) System Encapsulating Doxorubicin (DOX) and Glucose Oxidase (Gox) for Pancreatic Cancer Treatment. Int. J. Nanomed. 2023;18:7133-7147. doi: 10.2147/IJN.S436253. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]
What Is Silicon Dioxide? Simple Definition, Formula and Everyday Examples
What is silica (SiO₂)?
4N silica Experiments covering active targeting via surface functionalization.
What is the difference between fumed silica and precipitated silica?
fumed silica CAS 112945-52-5 35. Barguilla I., Candela-Noguera V., Oliver P., Annangi B., Díez P., Aznar E., Martínez-Máñez R., Marcos R., Hernández A., Marcos M.D. Toxicological Profiling and Long-Term Influences of Bare, PEGylated- and Galacto-Oligosaccharide-Functionalized Mesoporous Silica Nanoparticles. Int. J. Mol. Sci. 2023;24:16158. doi: 10.3390/ijms242216158. [ DOI ] [ PMC free post ] [ PubMed ] [ Google Scholar ]
What drives silica raw material prices?
wollastonite 82. Kumarasamy R.V., Natarajan P.M., Umapathy V.R., Roy J.R., Mironescu M., Palanisamy C.P. Clinical applications and therapeutic potentials of advanced nanoparticles: A comprehensive review on completed human clinical trials. Front. Nanotechnol. 2024;6:1479993. doi: 10.3389/fnano.2024.1479993. [ DOI ] [ Google Scholar ]
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.